Pediatric allergy and immunology in Brazil

Nelson A Rosario-Filho1, Cristina M Jacob, Dirceu Sole

  • 1Department of Pediatrics, Federal University of Parana, Curitiba, PR, Brazil. nelson.rosario@ufpr.br

Insights

Pediatric allergy and immunology in Brazil shows high asthma and food allergy prevalence. Research indicates reduced asthma hospitalizations but persistent indoor allergen risks, alongside advances in diagnosing primary immunodeficiencies.

Area of Science:

  • Pediatric Allergy and Immunology
  • Epidemiology
  • Immunology

Background:

  • The subspecialty of pediatric allergy and immunology in Brazil is developing.
  • This review examines research on allergic and immunologic diseases in Brazil.
  • It highlights disease characteristics and trends in the country.

Purpose of the Study:

  • To review research on pediatric allergic and immunologic diseases in Brazil.
  • To characterize the epidemiology of these conditions.
  • To assess the state of education and training in the field.

Main Methods:

  • Literature review of studies on pediatric allergy and immunology in Brazil.
  • Analysis of epidemiological data on asthma, food allergy, and anaphylaxis.
  • Examination of research on primary immunodeficiencies (PID).

Main Results:

  • High prevalence of asthma in children and adolescents, with reduced hospitalization rates.
  • Excessive indoor aeroallergen exposure and increased food allergy prevalence.
  • Key etiological agents for anaphylaxis identified; insights into PID, including fungal and mycobacterial infections.
  • Deficiencies in medical student education contrasted with effective residency programs.

Conclusions:

  • Pediatric allergy and immunology in Brazil is advancing, with significant disease burdens.
  • Further training is needed, particularly in primary immunodeficiencies.
  • Residency programs are effective, but undergraduate education requires improvement.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...